Stockreport

Longeveron® to Present at the 37th Annual Roth Conference

Longeveron Inc. - Class A Common stock  (LGVN) 
PDF MIAMI, March 05, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies fo [Read more]